• External genital warts and perianal warts – approved in Canada in January 1999
  • Actinic keratosis – approved in Canada in June 2004
  • Superficial basal cell carcinoma – approved in Canada in December 2004

Physician-initiated use

  • Common Warts
  • Hemangioma
  • Keloids
  • Lentigo Maligna
  • Leishmania
  • Molluscum Contagiosum
  • Nodular Basal Cell Carcinoma
  • Squamous Cell Carcinoma in situ.(Bowen’s disease)